TRIM63/IRF-8 axis promotes tumor progression and immunosuppression of melanoma with BRAF mutation

Fei Yi(Peking University Shenzhen Hospital), Bo Yu(Peking University Shenzhen Hospital)
Cell Death and Disease
November 28, 2025
Cited by 0


Related Papers